DGAP-Adhoc

Alphaform AG: Alphaform AG - Resolution on capital increase from authorised capital - purchase price for new shares at EUR 2.75

Alphaform AG / Key word(s): Capital Increase

15.09.2014 20:32

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Ad-hoc disclosure Alphaform AG

Alphaform AG - Resolution on capital increase from authorised capital -
purchase price for new shares at EUR 2.75

Feldkirchen, near Munich, 15 September 2014 - The Management Board of
Alphaform AG today resolved with the Supervisory Board's consent to
increase the company's share capital through partial utilisation of the
company's Authorised Capital in accordance with Article 5 (2) of the
company's articles of association by up to EUR 1,800,000.00 from EUR
5,850,000.00 at present to up to EUR 7,650,000.00 by issuing up to
1,800,000 new no-par value bearer shares, each with a pro rata share of the
share capital of EUR 1.00. The new shares are entitled to dividends as of 1
January 2014. A subscription right is granted to the shareholders.

The new shares are to be subscribed to by Close Brothers Seydler Bank AG,
Frankfurt am Main, and acquired with the obligation to offer them to
shareholders of Alphaform AG at a ratio of 13:4 with a purchase price of
EUR 2.75 per share. The three major shareholders LHUM Vermöghensverwaltungs
GmbH, Falk Strascheg Holding GmbH und Renate Strascheg Holding GmbH have
pledged to the company to exercise their subscription rights entirely. At
full placement, the company shall receive issue proceeds of up to EUR
4,950,000.00. The shareholders' subscription period is expected to begin on
18 September 2014 and conclude at the end of 6 October 2014.Unsubscribed
shares shall be offered to institutional and strategic investors at a fixed
purchase price as part of a private placement.


---------------------------------------------------------------------------

Information and Explaination of the Issuer to this News:

About Alphaform

Alphaform AG, based in Feldkirchen near Munich was founded in 1996. The
company belongs to the European market leaders in the production of complex
components means additive manufacturing, which are often grouped together
under the term '3D printing'. An important mainstay of the segment 3D
Printing an Additive Manufacturing ist the production of series close
prototypes, particularly for the automotive and capital goods industries.
The Medical Devision of Alphaform has al leading position throughout Europe
in manufacturing and processing orthopaedic implants and instruments. The
shares of alphaform are listed in the Prime Standard Segment of the